2024-09-11 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating hospitals and related facilities across multiple states.

**Performance Analysis:**

1. **Outperformance vs. S&P 500:** 
    * HCA has significantly outperformed the S&P 500 (VOO) with a cumulative return of 162.18% compared to VOO's 83.37%. 
    * This outperformance is reflected in the **relative divergence**, which sits at 94.17%, indicating that HCA's performance is currently significantly higher than the S&P 500 over the historical period.

2. **Recent Price Action:**
    * HCA's closing price is **$384.95**. 
    * It is currently trading below its **5-day moving average ($392.16)** but above both the **20-day ($383.18)** and **60-day ($352.56)** moving averages, suggesting potential short-term weakness but overall strong upward momentum.

3. **Technical Indicators:**
    * **RSI (63.44):** This suggests that HCA is currently in the overbought territory, indicating potential for a short-term pullback.
    * **PPO (-0.39):** The negative value indicates a short-term downtrend, supporting the RSI reading.
    * **Delta_Previous_Relative_Divergence (-5.3):** This indicates a recent decline in relative performance, further suggesting potential for a short-term correction.
    * **Expected_Return (5.04%):** This represents the potential annualized return over the next 5 years, based on current market conditions. 

4. **Recent Earnings and Outlook:**

| Date         | EPS   | Revenue       |
|--------------|-------|---------------|
| 2024-07-29  | 5.6   | 17.49 B$      |
| 2024-05-02  | 6.01  | 17.34 B$      |
| 2023-10-26  | 3.98  | 16.21 B$      |
| 2023-08-02  | 4.35  | 15.86 B$      |
| 2024-07-29  | 4.35  | 15.86 B$      | 

HCA's most recent earnings report (2024-07-29) showed EPS of $5.6, beating the analysts' consensus estimate of $5.35. Revenue also exceeded expectations, reaching $17.49 billion against an estimated $17.24 billion. This strong performance indicates continued growth and profitability for HCA.

**Summary:**

HCA has demonstrated significant outperformance against the S&P 500, reflecting its strong growth trajectory. While recent technical indicators suggest potential for a short-term pullback, the strong earnings report and positive outlook for the healthcare sector indicate potential for continued growth in the long-term. 

**Disclaimer:** This analysis is for informational purposes only and does not constitute investment advice. Before making any investment decisions, it is important to conduct thorough research and consult with a qualified financial advisor.